A Study to Evaluate the Safety and Efficacy of HB0052 in Patients With Advanced Solid Tumors
Clinical trial NCT06992687 · ENROLLING_BY_INVITATION
Trial details
- NCT number
- NCT06992687
- Sponsor
- Shanghai Huaota Biopharmaceutical Co., Ltd.
- Status
- ENROLLING_BY_INVITATION
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-09-01
- Primary completion
- 2025-09-30
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.